Response rates and minimal residual disease outcomes as potential surrogates for progression-free survival in newly diagnosed multiple myeloma
暂无分享,去创建一个
J. Cappelleri | A. Forsythe | G. Tremblay | T. Bell | C. Mamolo | A. Neuhof | P. Daniele | M. Musat